Form 8-K - Current report:
SEC Accession No. 0001683168-24-008332
Filing Date
2024-11-21
Accepted
2024-11-21 16:01:10
Documents
13
Period of Report
2024-11-21
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm   iXBRL 8-K 29952
  Complete submission text file 0001683168-24-008332.txt   206103

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE snoa-20241121.xsd EX-101.SCH 3027
3 XBRL LABEL FILE snoa-20241121_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE snoa-20241121_pre.xml EX-101.PRE 24173
15 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3667
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 241484164
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)